AEGISVOPAK - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 2.8
| Stock Code | AEGISVOPAK | Market Cap | 21,578 Cr. | Current Price | 195 ₹ | High / Low | 302 ₹ |
| Stock P/E | 121 | Book Value | 42.2 ₹ | Dividend Yield | 0.00 % | ROCE | 6.53 % |
| ROE | 7.70 % | Face Value | 10.0 ₹ | DMA 50 | 197 ₹ | DMA 200 | 225 ₹ |
| Chg in FII Hold | -0.14 % | Chg in DII Hold | -0.09 % | PAT Qtr | 51.1 Cr. | PAT Prev Qtr | 49.0 Cr. |
| RSI | 52.3 | MACD | 1.05 | Volume | 4,14,864 | Avg Vol 1Wk | 12,04,132 |
| Low price | 158 ₹ | High price | 302 ₹ | PEG Ratio | 0.33 | Debt to equity | 0.40 |
| 52w Index | 25.6 % | Qtr Profit Var | 50.3 % | EPS | 1.65 ₹ | Industry PE | 57.2 |
📊 Analysis: AEGISVOPAK shows weak profitability metrics with ROCE at 6.53% and ROE at 7.70%, far below ideal levels for long-term compounding. The P/E ratio of 121 is extremely high compared to the industry average of 57.2, suggesting significant overvaluation. EPS is low at 1.65 ₹, and dividend yield is 0%, offering no income support. While the PEG ratio of 0.33 indicates potential undervaluation relative to growth, the overall fundamentals remain weak.
💰 Entry Price Zone: Safer accumulation would be below 170 ₹ – 180 ₹, closer to the 52-week low (158 ₹), as current valuations do not justify entry at 195 ₹.
📈 Exit Strategy / Holding Period: If already holding, consider a short-to-medium horizon (1–2 years) and exit near 240 ₹ – 260 ₹ if momentum improves. Long-term holding is not recommended unless ROE/ROCE improve significantly and earnings growth sustains. Monitor quarterly PAT trends and institutional activity before extending holding period.
✅ Positive
- PEG ratio of 0.33 suggests potential undervaluation if growth sustains.
- Quarterly PAT growth (51.1 Cr vs 49.0 Cr) shows slight improvement.
- Profit variation of +50.3% indicates some earnings momentum.
⚠️ Limitation
- Extremely high P/E (121) compared to industry average (57.2).
- Weak ROCE (6.53%) and ROE (7.70%) limit efficiency.
- No dividend yield, reducing investor income appeal.
- Decline in both FII (-0.14%) and DII (-0.09%) holdings.
📉 Company Negative News
- No major negative news reported, but weak fundamentals and high valuation are concerns.
📈 Company Positive News
- Quarterly profit variation of +50.3% shows earnings growth.
- Stable PAT improvement quarter-on-quarter.
🏭 Industry
- Industry P/E at 57.2 indicates moderate sector valuation.
- Logistics and storage sector benefits from rising demand, but competition remains high.
🔎 Conclusion
AEGISVOPAK is currently overvalued with weak profitability metrics, making it a risky candidate for long-term investment. Entry is only advisable near 170 ₹ – 180 ₹ for better margin of safety. Existing holders should consider exiting near 240 ₹ – 260 ₹ unless fundamentals improve significantly. Long-term compounding potential is limited unless ROE and ROCE strengthen.